New targets for treatment of invasive breast cancer identified
August 20th, 2009 - 5:42 pm ICT by ANIWashington, Aug 20 (ANI): Scientists in the U.S have discovered new targets for the treatment of invasive breast cancer.
A new study, led by Suresh Alahari, PhD, Associate Professor of Biochemistry and Molecular Biology Louisiana State University Health Sciences Center New Orleans, has shown for the first time that a tiny piece of RNA appears to play a major role in the development of invasive breast cancer and identified a gene that appears to inhibit invasive breast cancer.
The LSUHSC researchers are the first to show that miR-27b, a novel microRNA, not only inactivates the ST14 gene which they found suppresses the growth of breast tumour cells, but also that miR-27b stimulates the breast cancer to invade other cells.
MicroRNAs are a new class of small, single-stranded RNA molecules that play an important regulatory role in cell biology.
They bind to target genes and decrease their function. MicroRNAs may act as oncogenes (a gene that contributes to cancer development) or tumor suppressors.
In this study working with a line of human breast cancer cells, Alahari’s team found that aggressively invasive breast tumour cells contain a large quantity of miR-27b molecules, while normal cells do not.
Further analysis revealed that miR-27b increases during cancer progression, in direct proportion to the decrease in function of the ST14 gene.
They found that miR-27b promotes cell growth and cell invasion, suggesting that miR-27b acts as a breast cancer oncogene.
They also found that ST14 inhibits both cell growth and cell invasion, suggesting that ST14 is a breast cancer tumour suppressor gene and that it may also serve as a marker for the early detection of breast cancer.
“We are in the process of confirming these results and these studies will reveal whether ST14 can reduce breast tumour growth in animals. Blocking the miR-27b/ST14 interaction or rescuing ST14 function may be an effective therapeutic approach to advance breast cancer treatment,” Alahari said.
The study has been published in the August 21, 2009 issue of the Journal of Biological Chemistry. (ANI)
- MicroRNAs could increase amputation risk in diabetics - Jan 13, 2011
- RNA-based drugs may prevent premature labour - Nov 16, 2010
- New discovery may help in the fight against ovarian cancer - Feb 04, 2011
- Scientists convert skin cells to stem cells more effieciently - Feb 03, 2011
- New discovery could shrink dengue-spreading mosquito population - Dec 03, 2010
- New discovery shows promise against pancreatic cancer - Dec 16, 2010
- Scientists discover cancer treatment in 'junk DNA' - Sep 29, 2010
- Lung cancer culprit could offer therapeutic target - Sep 14, 2010
- Micro-RNA decides malignancy of lung cancer - Sep 09, 2010
- Boffins identify 'gas pedal', 'brake' for uncontrolled cell growth - Aug 02, 2010
- How ovarian cancer resists chemotherapy - Mar 03, 2011
- Key enzyme in melanoma cell development found - Jun 18, 2010
- Scientists uncover clues to cancer development in AIDS patients - Jun 18, 2009
- Key step in body's ability to make red blood cells found - Aug 01, 2010
- New way to slow growth of deadly skin cancer - Jul 09, 2010
Tags: biochemistry and molecular biology, breast cancer, breast cancer cells, cancer development, cancer progression, cell biology, cell invasion, direct proportion, early detection of breast cancer, health sciences center, human breast cancer, invasive breast cancer, louisiana state university, louisiana state university health, louisiana state university health sciences center, louisiana state university health sciences center new o, rna molecules, tumor suppressors, university health sciences, university health sciences center